| Bioactivity | Oreptacog alfa is a recombinant DNA derived human blood coagulation factor VIIa. Oreptacog alfa can be used for the research of hemophilia, congenital factor VII deficiency and Glanzmann's thrombasthenia (GT)[1][2]. |
| Name | Oreptacog alfa |
| CAS | 1360054-92-7 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. International Nonproprietary Names (INN) for biological and biotechnological substances (a review) 2014. INN Bio Review 2014. [2]. Persson E, Olsen OH. Allosteric activation of coagulation factor VIIa. Front Biosci (Landmark Ed). 2011 Jun 1;16(8):3156-63. |